InvestorsHub Logo
Post# of 253152
Next 10
Followers 840
Posts 120462
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Thursday, 09/18/2014 10:35:54 AM

Thursday, September 18, 2014 10:35:54 AM

Post# of 253152
ProQR Therapeutics (PRQR) IPOs 8.6M* shares @$13.00 and is already +51% in the first hour:

http://finance.yahoo.com/news/proqr-announces-pricing-initial-public-120727024.html

[ProQR is] an innovative biopharmaceutical company engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis. Utilizing our unique, proprietary RNA repair technologies, we believe we will be able to treat genetic disorders in which a single protein is defective due to certain types of genetic mutation. We believe that this is a unique approach that offers advantages compared with small molecule, gene therapy and other therapeutic strategies.

*Assuming exercise of underwriter’s option.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.